Skip to content
Home/Companies/Pharma/Cinclus Pharma
CP

Cinclus Pharma

Pharma·Sweden·Active·0yr hold

Cinclus Pharma is a pharma company, headquartered in Sweden.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Cinclus Pharma?

Cinclus Pharma is currently owned by Claret Capital Partners through Claret European Growth Capital Fund IV (2025 vintage), since 2026.

Hand-verified · updated 2026-07-17

Claret Capital Partners
Investor
Claret Capital Partners
Claret European Growth Capital Fund IV · 2025 · Private Debt

Key facts

HQSweden
SectorPharma
StatusActive

More from Claret European Growth Capital Fund IV

Other portfolio companies in the same fund.

ACT Lab
Active
HealthcareUnited States· 2026
Inventiva
Active
BiotechFrance· 2026
Deciphex
Active
MedTechIreland· 2025
Fund Recs
Active
FintechIreland· 2025
Mindler
Active
HealthTechSweden· 2025
Montonio
Active
FintechEstonia· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Data refreshed weekly · Sourced from public filings